EXECUTIVE
SUMMARY
i.
Hydrocephalus Shunts
a. Market Analysis
ii.
Aneurysm Clips, Coils, and Intracranial Stents
a. Market Analysis
iii.
Neuroendoscopes
a. Market Analysis
iv. Image-Guided and Stereotactic
Surgical Navigation Systems
a. Market Analysis
v.
Neurointerventional Devices
a. Market Analysis
vi.
Deep Brain Stimulation Devices
a. Market Analysis
vii.
Vagus Nerve Stimulation Devices
a. Market Analysis
viii.
Combined Market Analysis
ix.
Methodology
Exhibit ES-1: Europe, Hydrocephalus
Shunts, Market Forecast, 2002-2012
Exhibit ES-2: Europe, Aneurysm
Clips, Coils, and Intracranial Stents, Market Forecast, 2002-2012
Exhibit ES-3: Europe, Neuroendoscopes,
Market Forecast, 2002-2012
Exhibit ES-4: Europe, Image-Guided
and Stereotactic Surgical Navigation Systems, Market Forecast,
2002-2012
Exhibit ES-5: Europe, Neurointerventional
Products, Market Forecast, 2002-2012
Exhibit ES-6: Europe, Deep Brain
Stimulation Products, Market Forecast, 2002-2012
Exhibit ES-7: Europe, Vagus Nerve
Stimulation Products, Market Forecast, 2002-2012
Exhibit ES-8: Europe, Neurosurgical
and Neurointerventional Products, Combined Market Forecast,
2002-2012
1. OVERVIEW OF THE EUROPEAN HEALTHCARE
MARKET
1.1
The European Union
1.1.1 A Common Currency
1.1.2 Regulatory Policies
1.1.3 Reimbursement
1.1.4 Healthcare Spending
1.2
Selected European National Healthcare Profiles
1.2.1 France
1.2.1.1 Healthcare Organization and Reform
1.2.1.2 Hospital Services
1.2.1.3 Medical Device Reimbursement
1.2.2 Germany
1.2.2.1 Healthcare Organization and Reform
1.2.2.2 Hospital Services
1.2.2.3 Medical Device Reimbursement
1.2.3 Italy
1.2.3.1 Healthcare Organization and Reform
1.2.3.2 Hospital Services
1.2.3.3 Medical Device Reimbursement
1.2.4 Spain
1.2.4.1 Healthcare Organization and Reform
1.2.4.2 Hospital Services
1.2.4.3 Medical Device Reimbursement
1.2.5 United Kingdom
1.2.5.1 Healthcare Organization and Reform
1.2.5.2 Hospital Services
1.2.5.3 Medical Device Reimbursement
1.2.6 The Benelux Countries
1.2.6.1 Healthcare Organization and Reform
1.2.6.1.1 Belgium
1.2.6.1.2 Luxembourg
1.2.6.1.3 The Netherlands
1.2.6.2 Hospital Services
1.2.6.3 Medical Device Reimbursement
1.2.7 The Nordic Countries
1.2.7.1 Healthcare Organization and Reform
1.2.7.1.1 Denmark
1.2.7.1.2 Finland
1.2.7.1.3 Norway
1.2.7.1.4 Sweden
1.2.7.2 Hospital Services
1.2.7.3 Medical Device Reimbursement
Exhibit 1-1: European Union,
Medical Devices Risk Classification System
Exhibit 1-2: European Union,
Population Statistics Comparison, 1996 and 2006
Exhibit 1-3: France, Selected
National Healthcare Statistics
Exhibit 1-4: Germany, Selected
National Healthcare Statistics
Exhibit 1-5: Italy, Selected
National Healthcare Statistics
Exhibit 1-6: Spain, Selected
National Healthcare Statistics
Exhibit 1-7: United Kingdom,
Selected National Healthcare Statistics
Exhibit 1-8: Belgium, Selected
National Healthcare Statistics
Exhibit 1-9: Luxembourg, Selected
National Healthcare Statistics
Exhibit 1-10: The Netherlands,
Selected National Healthcare Statistics
Exhibit 1-11: Denmark, Selected
National Healthcare Statistics
Exhibit 1-12: Finland, Selected
National Healthcare Statistics
Exhibit 1-13: Norway, Selected
National Healthcare Statistics
Exhibit 1-14: Sweden, Selected
National Healthcare Statistics
2.
CLINICAL AND TREATMENT OVERVIEW
2.1
Overview of the Central Nervous System
2.1.1 The Brain and Cerebrovascular System
2.1.2 The Peripheral Nervous System
2.2 Neurologic Disorders of the Brain
and Cerebrovascular System
2.2.1 Alzheimer’s Disease
2.2.1.1 Etiology
2.2.1.2 Incidence and Prevalence
2.2.1.3 Treatment Options
2.2.1.3.1 Drug Therapy
2.2.1.3.2 Device-Based Therapy
2.2.1.3.3 Surgery
2.2.2 Parkinson’s Disease
2.2.2.1 Etiology
2.2.2.2 Incidence and Prevalence
2.2.2.3 Treatment Options
2.2.2.3.1 Drug Therapy
2.2.2.3.2 Device-Based Therapy
2.2.2.3.3 Surgery
2.2.2.3.4 Other
2.2.3 Multiple Sclerosis
2.2.3.1 Etiology
2.2.3.2 Incidence and Prevalence
2.2.3.3 Treatment Options
2.2.3.3.1 Drug Therapy
2.2.3.3.2 Device-Based Therapy
2.2.3.3.3 Surgery
2.2.4 Epilepsy
2.2.4.1 Etiology
2.2.4.2 Incidence and Prevalence
2.2.4.3 Treatment Options
2.2.4.3.1 Drug Therapy
2.2.4.3.2 Device-Based Therapy
2.2.4.3.3 Surgery
2.2.5 Stroke
2.2.5.1 Etiology
2.2.5.2 Incidence and Prevalence
2.2.5.3 Treatment Options
2.2.5.3.1 Drug Therapy
2.2.5.3.2 Device-Based Therapy
2.2.6 Cerebral Aneurysms
2.2.6.1 Etiology
2.2.6.2 Incidence and Prevalence
2.2.6.3 Treatment Options
2.2.6.3.1 Drug Therapy
2.2.6.3.2 Device-Based Therapy
2.2.6.3.3 Surgery
2.2.6.3.4 Other
2.2.7 Tumors of the Brain or Central
Nervous System
2.2.7.1 Etiology
2.2.7.2 Incidence and Prevalence
2.2.7.3 Treatment Options
2.2.7.3.1 Drug Therapy
2.2.7.3.2 Device-Based Therapy
2.2.7.3.3 Surgery
2.2.7.3.4 Other
2.2.8 Hydrocephalus
2.2.8.1 Etiology
2.2.8.2 Incidence and Prevalence
2.2.8.3 Treatment Options
2.2.8.3.1 Drug Therapy
2.2.8.3.2 Device-Based Therapy
2.2.8.3.3 Surgery
2.2.8.3.4 Other
2.2.9 Head Trauma
2.2.9.1 Etiology
2.2.9.2 Incidence and Prevalence
2.2.9.3 Treatment Options
2.2.9.3.1 Drug Therapy
2.2.9.3.2 Device-Based Therapy
2.2.9.3.3 Surgery
Exhibit 2-1: Structural Relationship
Between the Brainstem, Cerebellum, and Cerebrum
Exhibit 2-2: Structure of the
Arteries Supplying Blood to the Brain
Exhibit 2-3: Europe, Deaths Attributable
to Neurologic Disorders, by Cause, World Health Organization
Region (Europe—Very Low Child, Very Low Adult Mortality), and
Mortality Stratum, 2005, 2015, and 2030
Exhibit 2-4: Europe, Deaths Attributable
to Neurologic Disorders, by Cause, World Health Organization
Region (Europe—Low Child, Low Adult Mortality), and Mortality
Stratum, 2005, 2015, and 2030
Exhibit 2-5: Europe, Deaths Attributable
to Neurologic Disorders, by Cause, World Health Organization
Region (Europe—Low Child, High Adult Mortality), and Mortality
Stratum, 2005, 2015, and 2030
Exhibit 2-6: Dementia, Prevalence
Rates, Selected European Countries
Exhibit 2-7: Multiple Sclerosis,
Prevalence Rates, Selected European Countries
Exhibit 2-8: Epilepsy, Prevalence,
Selected World Regions
Exhibit 2-9: Epilepsy, Mean Number
of People with the Disorder Per 1,000 Population, Selected World
Regions
Exhibit 2-10: 2004, Europe, Deaths/All
Causes, Deaths/Stroke for Men
Exhibit 2-11: 2004, Europe, Deaths/All
Causes, Deaths/Stroke for Women
Exhibit 2-12: Distribution of Primary
Gliomas of the Brain and Central Nervous System
Exhibit 2-13: Tumors of the Brain
and Central Nervous System, Incidence Rates, Selected European
Countries
Exhibit 2-14: Aggregate Hospitalized
plus Fatal Traumatic Brain Injury, Incidence Rates, Selected
European Countries
3. EUROPEAN MARKETS FOR HYDROCEPHALUS
SHUNTS
3.1
Technology Overview
3.2
Products
3.3
Market Analysis
3.3.1 Market Overview
3.3.2 Market Drivers
3.3.3 Market Limiters
3.3.4 National Markets
3.3.5 Competitive Analysis
Exhibit 3-1: 2007, Selected Hydrocephalus
Shunts
Exhibit 3-2: Europe, Hydrocephalus
Shunts, Market Forecast, 2002-2012
Exhibit 3-3: France, Hydrocephalus
Shunts, Market Forecast, 2002-2012
Exhibit 3-4: Germany, Hydrocephalus
Shunts, Market Forecast, 2002-2012
Exhibit 3-5: Italy, Hydrocephalus
Shunts, Market Forecast, 2002-2012
Exhibit 3-6: Spain, Hydrocephalus
Shunts, Market Forecast, 2002-2012
Exhibit 3-7: United Kingdom,
Hydrocephalus Shunts, Market Forecast, 2002-2012
Exhibit 3-8: Benelux Countries,
Hydrocephalus Shunts, Market Forecast, 2002-2012
Exhibit 3-9: Nordic Countries,
Hydrocephalus Shunts, Market Forecast, 2002-2012
Exhibit 3-10: Rest of Europe, Hydrocephalus
Shunts, Market Forecast, 2002-2012
Exhibit 3-11: 2006, Europe, Hydrocephalus
Shunts Market, Share by Supplier
Exhibit 3-12: 2006, France, Hydrocephalus
Shunts Market, Share by Supplier
Exhibit 3-13: 2006, Germany, Hydrocephalus
Shunts Market, Share by Supplier
Exhibit 3-14: 2006, Italy, Hydrocephalus
Shunts Market, Share by Supplier
Exhibit 3-15: 2006, Spain, Hydrocephalus
Shunts Market, Share by Supplier
Exhibit 3-16: 2006, United Kingdom,
Hydrocephalus Shunts Market, Share by Supplier
Exhibit 3-17: 2006, Benelux Countries,
Hydrocephalus Shunts Market, Share by Supplier
Exhibit 3-18: 2006, Nordic Countries,
Hydrocephalus Shunts Market, Share by Supplier
Exhibit 3-19: 2006, Rest of Europe,
Hydrocephalus Shunts Market, Share by Supplier
4. EUROPEAN MARKETS FOR ANEURYSM CLIPS,
COILS, AND INTRACRANIAL STENTS
4.1
Technology Overview
4.1.1 Clipping
4.1.2 Coil Placement
4.1.3 Stenting
4.2.
Products
4.3
Market Analysis
4.3.1 Market Overview
4.3.2 Market Drivers
4.3.3 Market Limiters
4.3.4 National Markets
4.3.5 Competitors
Exhibit 4-1: 2007, Selected Aneurysm
Clips, Coils, and Intracranial Stents
Exhibit 4-2: Europe, Aneurysm
Clips, Coils, and Intracranial Stents, Market Forecast, 2002-2012
Exhibit 4-3: France, Aneurysm
Clips, Coils, and Intracranial Stents, Market Forecast, 2002-2012
Exhibit 4-4: Germany, Aneurysm
Clips, Coils, and Intracranial Stents, Market Forecast, 2002-2012
Exhibit 4-5: Italy, Aneurysm
Clips, Coils, and Intracranial Stents, Market Forecast, 2002-2012
Exhibit 4-6: Spain, Aneurysm
Clips, Coils, and Intracranial Stents, Market Forecast, 2002-2012
Exhibit 4-7: United Kingdom,
Aneurysm Clips, Coils, and Intracranial Stents, Market Forecast,
2002-2012
Exhibit 4-8: Benelux Countries,
Aneurysm Clips, Coils, and Intracranial Stents, Market Forecast,
2002-2012
Exhibit 4-9: Nordic Countries,
Aneurysm Clips, Coils, and Intracranial Stents, Market Forecast,
2002-2012
Exhibit 4-10: Rest of Europe, Aneurysm
Clips, Coils, and Intracranial Stents, Market Forecast, 2002-2012
Exhibit 4-11: 2006, Europe, Aneurysm
Clips, Coils, and Intracranial Stents Market, Share by Supplier
Exhibit 4-12: 2006, France, Aneurysm
Clips, Coils, and Intracranial Stents Market, Share by Supplier
Exhibit 4-13: 2006, Germany, Aneurysm
Clips, Coils, and Intracranial Stents Market, Share by Supplier
Exhibit 4-14: 2006, Italy, Aneurysm
Clips, Coils, and Intracranial Stents Market, Share by Supplier
Exhibit 4-15: 2006, Spain, Aneurysm
Clips, Coils, and Intracranial Stents Market, Share by Supplier
Exhibit 4-16: 2006, United Kingdom,
Aneurysm Clips, Coils, and Intracranial Stents Market, Share
by Supplier
Exhibit 4-17: 2006, Benelux Countries,
Aneurysm Clips, Coils, and Intracranial Stents Market, Share
by Supplier
Exhibit 4-18: 2006, Nordic Countries,
Aneurysm Clips, Coils, and Intracranial Stents Market, Share
by Supplier
Exhibit 4-19: 2006, Rest of Europe,
Aneurysm Clips, Coils, and Intracranial Stents Market, Share
by Supplier
5.
EUROPEAN MARKETS FOR NEUROENDOSCOPES
5.1
Technology Overview
5.2
Products
5.3
Market Analysis
5.3.1 Market Overview
5.3.2 Market Drivers
5.3.3 Market Limiters
5.3.4 National Markets
5.3.5 Competitive Analysis
Exhibit 5-1: 2007, Selected Neuroendoscopes
Exhibit 5-2: Europe, Neuroendoscopes,
Market Forecast, 2002-2012
Exhibit 5-3: France, Neuroendoscopes,
Market Forecast, 2002-2012
Exhibit 5-4: Germany, Neuroendoscopes,
Market Forecast, 2002-2012
Exhibit 5-5: Italy, Neuroendoscopes,
Market Forecast, 2002-2012
Exhibit 5-6: Spain, Neuroendoscopes,
Market Forecast, 2002-2012
Exhibit 5-7: United Kingdom,
Neuroendoscopes, Market Forecast, 2002-2012
Exhibit 5-8: Benelux Countries,
Neuroendoscopes, Market Forecast, 2002-2012
Exhibit 5-9: Nordic Countries,
Neuroendoscopes, Market Forecast, 2002-2012
Exhibit 5-10: Rest of Europe, Neuroendoscopes,
Market Forecast, 2002-2012
Exhibit 5-11: 2006, Europe, Neuroendoscopes
Market, Share by Supplier
Exhibit 5-12: 2006, France, Neuroendoscopes
Market, Share by Supplier
Exhibit 5-13: 2006, Germany, Neuroendoscopes
Market, Share by Supplier
Exhibit 5-14: 2006, Italy, Neuroendoscopes
Market, Share by Supplier
Exhibit 5-15: 2006, Spain, Neuroendoscopes
Market, Share by Supplier
Exhibit 5-16: 2006, United Kingdom,
Neuroendoscopes Market, Share by Supplier
Exhibit 5-17: 2006, Benelux Countries,
Neuroendoscopes Market, Share by Supplier
Exhibit 5-18: 2006, Nordic Countries,
Neuroendoscopes Market, Share by Supplier
Exhibit 5-19: 2006, Rest of Europe,
Neuroendoscopes Market, Share by Supplier
6. EUROPEAN MARKETS FOR IMAGE-GUIDED
AND STEREOTACTIC SURGICAL NAVIGATION SYSTEMS
6.1
Technology Overview
6.1.1 Image-Guided Surgical Navigation
6.1.1.1 Products
6.1.2 Stereotactic Surgical Navigation
6.1.2.1 Frame-Based Stereotactic Devices
6.1.2.1.1 Products
6.1.2.2 Frameless Stereotactic Devices
6.1.2.2.1 Products
6.2
Market Analysis
6.2.1 Market Overview
6.2.2 Market Drivers
6.2.3 Market Limiters
6.2.4 National Markets
6.2.5 Competitive Analysis
Exhibit 6-1: 2007, Selected Image-Guided
Surgical Navigation Systems
Exhibit 6-2: 2007, Selected Frame-Based
Stereotactic Systems
Exhibit 6-3: 2007, Selected Frameless
Stereotactic Systems
Exhibit 6-4: Europe, Image-Guided
and Frame-Based and Frameless Stereotactic Surgical Navigation
Systems, Market Forecast, 2002-2012
Exhibit 6-5: Europe, Frame-Based
Stereotactic Devices, Market Forecast, 2002-2012
Exhibit 6-6: Europe, Frameless
Stereotactic Devices, Market Forecast, 2002-2012
Exhibit 6-7: Europe, Image-Guided
Surgical Navigation Systems, Market Forecast, 2002-2012
Exhibit 6-8: France, Image-Guided
and Frame-Based and Frameless Stereotactic Surgical Navigation
Systems, Market Forecast, 2002-2012
Exhibit 6-9: Germany, Image-Guided
and Frame-Based and Frameless Stereotactic Surgical Navigation
Systems, Market Forecast, 2002-2012
Exhibit 6-10: Italy, Image-Guided
and Frame-Based and Frameless Stereotactic Surgical Navigation
Systems, Market Forecast, 2002-2012
Exhibit 6-11: Spain, Image-Guided
and Frame-Based and Frameless Stereotactic Surgical Navigation
Systems, Market Forecast, 2002-2012
Exhibit 6-12: United Kingdom, Image-Guided
and Frame-Based and Frameless Stereotactic Surgical Navigation
Systems, Market Forecast, 2002-2012
Exhibit 6-13: Benelux Countries,
Image-Guided and Frame-Based and Frameless Stereotactic Surgical
Navigation Systems, Market Forecast, 2002-2012
Exhibit 6-14: Nordic Countries,
Image-Guided and Frame-Based and Frameless Stereotactic Surgical
Navigation Systems, Market Forecast, 2002-2012
Exhibit 6-15: Rest of Europe, Image-Guided
and Frame-Based and Frameless Stereotactic Surgical Navigation
Systems, Market Forecast, 2002-2012
Exhibit 6-16: France, Frame-Based
Stereotactic Devices, Market Forecast, 2002-2012
Exhibit 6-17: Germany, Frame-Based
Stereotactic Devices, Market Forecast, 2002-2012
Exhibit 6-18: Italy, Frame-Based
Stereotactic Devices, Market Forecast, 2002-2012
Exhibit 6-19: Spain, Frame-Based
Stereotactic Devices, Market Forecast, 2002-2012
Exhibit 6-20: United Kingdom, Frame-Based
Stereotactic Devices, Market Forecast, 2002-2012
Exhibit 6-21: Benelux Countries,
Frame-Based Stereotactic Devices, Market Forecast, 2002-2012
Exhibit 6-22: Nordic Countries,
Frame-Based Stereotactic Devices, Market Forecast, 2002-2012
Exhibit 6-23: Rest of Europe, Frame-Based
Stereotactic Devices, Market Forecast, 2002-2012
Exhibit 6-24: France, Frameless
Stereotactic Devices, Market Forecast, 2002-2012
Exhibit 6-25: Germany, Frameless
Stereotactic Devices, Market Forecast, 2002-2012
Exhibit 6-26: Italy, Frameless
Stereotactic Devices, Market Forecast, 2002-2012
Exhibit 6-27: Spain, Frameless
Stereotactic Devices, Market Forecast, 2002-2012
Exhibit 6-28: United Kingdom, Frameless
Stereotactic Devices, Market Forecast, 2002-2012
Exhibit 6-29: Benelux Countries,
Frameless Stereotactic Devices, Market Forecast, 2002-2012
Exhibit 6-30: Nordic Countries,
Frameless Stereotactic Devices, Market Forecast, 2002-2012
Exhibit 6-31: Rest of Europe, Frameless
Stereotactic Devices, Market Forecast, 2002-2012
Exhibit 6-32: France, Image-Guided
Surgical Navigation Systems, Market Forecast, 2002-2012
Exhibit 6-33: Germany, Image-Guided
Surgical Navigation Systems, Market Forecast, 2002-2012
Exhibit 6-34: Italy, Image-Guided
Surgical Navigation Systems, Market Forecast, 2002-2012
Exhibit 6-35: Spain, Image-Guided
Surgical Navigation Systems, Market Forecast, 2002-2012
Exhibit 6-36: United Kingdom, Image-Guided
Surgical Navigation Systems, Market Forecast, 2002-2012
Exhibit 6-37: Benelux Countries,
Image-Guided Surgical Navigation Systems, Market Forecast, 2002-2012
Exhibit 6-38: Nordic Countries,
Image-Guided Surgical Navigation Systems, Market Forecast, 2002-2012
Exhibit 6-39: Rest of Europe, Image-Guided
Surgical Navigation Systems, Market Forecast, 2002-2012
Exhibit 6-40: 2006, Europe, Image-Guided
and Frame-Based and Frameless Stereotactic Surgical Navigation
Systems Market, Share by Supplier
Exhibit 6-41: 2006, Europe, Frame-Based
Stereotactic Devices Market, Share by Supplier
Exhibit 6-42: 2006, Europe, Frameless
Stereotactic Devices Market, Share by Supplier
Exhibit 6-43: 2006, Europe, Image-Guided
Surgical Navigation Systems Market, Share by Supplier
Exhibit 6-44: 2006, France, Image-Guided
and Frame-Based and Frameless Stereotactic Surgical Navigation
Systems Market, Share by Supplier
Exhibit 6-45: 2006, Germany, Image-Guided
and Frame-Based and Frameless Stereotactic Surgical Navigation
Systems Market, Share by Supplier
Exhibit 6-46: 2006, Italy, Image-Guided
and Frame-Based and Frameless Stereotactic Surgical Navigation
Systems Market, Share by Supplier
Exhibit 6-47: 2006, Spain, Image-Guided
and Frame-Based and Frameless Stereotactic Surgical Navigation
Systems Market, Share by Supplier
Exhibit 6-48: 2006, United Kingdom,
Image-Guided and Frame-Based and Frameless Stereotactic Surgical
Navigation Systems Market, Share by Supplier
Exhibit 6-49: 2006, Benelux Countries,
Image-Guided and Frame-Based and Frameless Stereotactic Surgical
Navigation Systems Market, Share by Supplier
Exhibit 6-50: 2006, Nordic Countries,
Image-Guided and Frame-Based and Frameless Stereotactic Surgical
Navigation Systems Market, Share by Supplier
Exhibit 6-51: 2006, Rest of Europe,
Image-Guided and Frame-Based and Frameless Stereotactic Surgical
Navigation Systems Market, Share by Supplier
7.
EUROPEAN MARKETS FOR NEUROINTERVENTIONAL DEVICES
7.1
Technology Overview
7.1.1 Carotid Endarterectomy
7.1.2 Carotid Artery Stenting
7.1.3 Cerebral Balloon Angioplasty
7.1.4 Mechanical Thrombectomy
7.2
Products
7.2.1 Microcatheters and Microguidewires
7.2.2 Balloon Angioplasty Systems
7.2.3 Carotid Artery Stents
7.2.4 Embolic Protection Systems
7.2.4.1 Distal Filter Devices
7.2.4.2 Balloon Occlusion Devices
7.2.4.2.1 Distal Balloon Occlusion
Devices
7.2.4.2.2 Proximal Balloon Occlusion
Devices
7.2.5 Mechanical Thrombectomy Systems
7.3
Market Analysis
7.3.1 Market Overview
7.3.2 Market Drivers
7.3.3 Market Limiters
7.3.4 National Markets
7.3.5 Competitive Analysis
Exhibit 7-1: 2007, Selected Neurointerventional
Microcatheters
Exhibit 7-2: 2007, Selected Neurointerventional
Microguidewires
Exhibit 7-3: 2007, Selected Neurointerventional
Balloon Angioplasty Systems
Exhibit 7-4: 2007, Selected Carotid
Artery Stents
Exhibit 7-5: 2007, Selected Distal
Filter Embolic Protection Systems
Exhibit 7-6: 2007, Selected Thrombectomy
Systems
Exhibit 7-7: Europe, Neurointerventional
Products, Market Forecast, 2002-2012
Exhibit 7-8: Europe, Carotid
Artery Stents, Market Forecast, 2002-2012
Exhibit 7-9: France, Carotid
Artery Stents, Market Forecast, 2002-2012
Exhibit 7-10: Germany, Carotid
Artery Stents, Market Forecast, 2002-2012
Exhibit 7-11: Italy, Carotid Artery
Stents, Market Forecast, 2002-2012
Exhibit 7-12: Spain, Carotid Artery
Stents, Market Forecast, 2002-2012
Exhibit 7-13: United Kingdom, Carotid
Artery Stents, Market Forecast, 2002-2012
Exhibit 7-14: Benelux Countries,
Carotid Artery Stents, Market Forecast, 2002-2012
Exhibit 7-15: Nordic Countries,
Carotid Artery Stents, Market Forecast, 2002-2012
Exhibit 7-16: Rest of Europe, Carotid
Artery Stents, Market Forecast, 2002-2012
Exhibit 7-17: Europe, Embolic Protection
Systems, Market Forecast, 2002-2012
Exhibit 7-18: France, Embolic Protection
Systems, Market Forecast, 2002-2012
Exhibit 7-19: Germany, Embolic
Protection Systems, Market Forecast, 2002-2012
Exhibit 7-20: Italy, Embolic Protection
Systems, Market Forecast, 2002-2012
Exhibit 7-21: Spain, Embolic Protection
Systems, Market Forecast, 2002-2012
Exhibit 7-22: United Kingdom, Embolic
Protection Systems, Market Forecast, 2002-2012
Exhibit 7-23: Benelux Countries,
Embolic Protection Systems, Market Forecast, 2002-2012
Exhibit 7-24: Nordic Countries,
Embolic Protection Systems, Market Forecast, 2002-2012
Exhibit 7-25: Rest of Europe, Embolic
Protection Systems, Market Forecast, 2002-2012
Exhibit 7-26: Europe, Microcatheters
and Microguidewires, Market Forecast, 2002-2012
Exhibit 7-27: France, Microcatheters
and Microguidewires, Market Forecast, 2002-2012
Exhibit 7-28: Germany, Microcatheters
and Microguidewires, Market Forecast, 2002-2012
Exhibit 7-29: Italy, Microcatheters
and Microguidewires, Market Forecast, 2002-2012
Exhibit 7-30: Spain, Microcatheters
and Microguidewires, Market Forecast, 2002-2012
Exhibit 7-31: United Kingdom, Microcatheters
and Microguidewires, Market Forecast, 2002-2012
Exhibit 7-32: Benelux Countries,
Microcatheters and Microguidewires, Market Forecast, 2002-2012
Exhibit 7-33: Nordic Countries,
Microcatheters and Microguidewires, Market Forecast, 2002-2012
Exhibit 7-34: Rest of Europe, Microcatheters
and Microguidewires, Market Forecast, 2002-2012
Exhibit 7-35: Europe, Neurointerventional
Balloon Angioplasty Systems, Market Forecast, 2002-2012
Exhibit 7-36: France, Neurointerventional
Balloon Angioplasty Systems, Market Forecast, 2002-2012
Exhibit 7-37: Germany, Neurointerventional
Balloon Angioplasty Systems, Market Forecast, 2002-2012
Exhibit 7-38: Italy, Neurointerventional
Balloon Angioplasty Systems, Market Forecast, 2002-2012
Exhibit 7-39: Spain, Neurointerventional
Balloon Angioplasty Systems, Market Forecast, 2002-2012
Exhibit 7-40: United Kingdom, Neurointerventional
Balloon Angioplasty Systems, Market Forecast, 2002-2012
Exhibit 7-41: Benelux Countries,
Neurointerventional Balloon Angioplasty Systems, Market Forecast,
2002-2012
Exhibit 7-42: Nordic Countries,
Neurointerventional Balloon Angioplasty Systems, Market Forecast,
2002-2012
Exhibit 7-43: Rest of Europe, Neurointerventional
Balloon Angioplasty Systems, Market Forecast, 2002-2012
Exhibit 7-44: Europe, Thrombectomy
Systems, Market Forecast, 2002-2012
Exhibit 7-45: France, Thrombectomy
Systems, Market Forecast, 2002-2012
Exhibit 7-46: Germany, Thrombectomy
Systems, Market Forecast, 2002-2012
Exhibit 7-47: Italy, Thrombectomy
Systems, Market Forecast, 2002-2012
Exhibit 7-48: Spain, Thrombectomy
Systems, Market Forecast, 2002-2012
Exhibit 7-49: United Kingdom, Thrombectomy
Systems, Market Forecast, 2002-2012
Exhibit 7-50: Benelux Countries,
Thrombectomy Systems, Market Forecast, 2002-2012
Exhibit 7-51: Nordic Countries,
Thrombectomy Systems, Market Forecast, 2002-2012
Exhibit 7-52: Rest of Europe, Thrombectomy
Systems, Market Forecast, 2002-2012
Exhibit 7-53: 2006, Europe, Neurointerventional
Products Market, Share by Supplier
Exhibit 7-54: 2006, France, Neurointerventional
Products Market, Share by Supplier
Exhibit 7-55: 2006, Germany, Neurointerventional
Products Market, Share by Supplier
Exhibit 7-56: 2006, Italy, Neurointerventional
Products Market, Share by Supplier
Exhibit 7-57: 2006, Spain, Neurointerventional
Products Market, Share by Supplier
Exhibit 7-58: 2006, United Kingdom,
Neurointerventional Products Market, Share by Supplier
Exhibit 7-59: 2006, Benelux Countries,
Neurointerventional Products Market, Share by Supplier
Exhibit 7-60: 2006, Nordic Countries,
Neurointerventional Products Market, Share by Supplier
Exhibit 7-61: 2006, Rest of Europe,
Neurointerventional Products Market, Share by Supplier
8. EUROPEAN MARKETS FOR DEEP BRAIN
STIMULATION PRODUCTS
8.1
Technology Overview
8.2
Products
8.3
Market Analysis
8.3.1 Market Overview
8.3.2 Market Drivers
8.3.3 Market Limiters
8.3.4 National Markets
8.3.5 Competitive Analysis
Exhibit 8-1: Deep Brain Stimulation
Exhibit 8-2: 2007, Selected Deep
Brain Stimulation Products
Exhibit 8-3: Europe, Deep Brain
Stimulation Products, Market Forecast, 2002-2012
Exhibit 8-4: France, Deep Brain
Stimulation Products, Market Forecast, 2002-2012
Exhibit 8-5: Germany, Deep Brain
Stimulation Products, Market Forecast, 2002-2012
Exhibit 8-6: Italy, Deep Brain
Stimulation Products, Market Forecast, 2002-2012
Exhibit 8-7: Spain, Deep Brain
Stimulation Products, Market Forecast, 2002-2012
Exhibit 8-8: United Kingdom,
Deep Brain Stimulation Products, Market Forecast, 2002-2012
Exhibit 8-9: Benelux Countries,
Deep Brain Stimulation Products, Market Forecast, 2002-2012
Exhibit 8-10: Nordic Countries,
Deep Brain Stimulation Products, Market Forecast, 2002-2012
Exhibit 8-11: Rest of Europe, Deep
Brain Stimulation Products, Market Forecast, 2002-2012
9. EUROPEAN MARKETS FOR VAGUS NERVE
STIMULATION PRODUCTS
9.1
Technology Overview
9.2
Products
9.3
Market Analysis
9.3.1 Market Overview
9.3.2 Market Drivers
9.3.3 Market Limiters
9.3.4 National Markets
9.3.5 Competitive Analysis
Exhibit 9-1: The Vagus Nerve
Exhibit 9-2: Advantages and Disadvantages
of Vagus Nerve Stimulation
Exhibit 9-3: Europe, Vagus Nerve
Stimulation Products, Market Forecast, 2002-2012
Exhibit 9-4: France, Vagus Nerve
Stimulation Products, Market Forecast, 2002-2012
Exhibit 9-5: Germany, Vagus Nerve
Stimulation Products, Market Forecast, 2002-2012
Exhibit 9-6: Italy, Vagus Nerve
Stimulation Products, Market Forecast, 2002-2012
Exhibit 9-7: Spain, Vagus Nerve
Stimulation Products, Market Forecast, 2002-2012
Exhibit 9-8: United Kingdom,
Vagus Nerve Stimulation Products, Market Forecast, 2002-2012
Exhibit 9-9: Benelux Countries,
Vagus Nerve Stimulation Products, Market Forecast, 2002-2012
Exhibit 9-10: Nordic Countries,
Vagus Nerve Stimulation Products, Market Forecast, 2002-2012
Exhibit 9-11: Rest of Europe, Vagus
Nerve Stimulation Products, Market Forecast, 2002-2012
10.
COMPANY PROFILES
10.1
Abbott Vascular/Abbott Laboratories
10.2
Boston Scientific Corporation
10.3
BrainLAB AG
10.4
B. Braun Melsungen AG
10.5
Cyberonics, Inc.
10.6
Elekta AB
10.7
Integra LifeSciences Holdings Corporation
10.8
Johnson & Johnson
10.9
Medtronic, Inc.
10.10
Micrus Endovascular Corporation
10.11
Christoph Miethke GMBH & Company KG
10.12
Mizuho Ikakogyo Company LTD
10.13
Olympus Corporation
10.14
Possis Medical, Inc.
10.15
PRAXIM medivision SA
10.16
Sophysa SA/Tokibo Group
10.17
KARL STORZ GmbH & Company KG
10.18
Richard Wolf GmbH
10.19
Zeppelin Medical Instruments GmbH
APPENDIX:
COMPANY LISTING